Kymera Therapeutics (KYMR) Non-Current Assets (2019 - 2026)
Kymera Therapeutics (KYMR) recorded Non-Current Assets of $908.18 million in Q2 2026, up 125.5% from $402.74 million a year earlier but down 8.4% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics reported Non-Current Assets of $871.6 million, up 86.3% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 36.4% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $467.77 million in FY2024 (+174.4%), $170.44 million in FY2023 (-7.2%), $183.72 million in FY2022 (+18.8%) and $154.63 million in FY2021 (-16.3%).
- Quarterly Non-Current Assets has ranged from $98.72 million in Q3 2021 to $991.58 million in Q1 2026 over the past five years.
- On a year-over-year basis, Non-Current Assets has increased for ten consecutive quarters, with growth averaging 96.4% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 174.4% in Q4 2024, against a decline of 53.0% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $991.58 million (Q1 2026), $871.6 million (Q4 2025) and $573.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Kymera Therapeutics | 9.27 Bn | 6.58 Bn | - | 908.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 908.18 Mn |
| Mar 31, 2026 | 991.58 Mn |
| Dec 31, 2025 | 871.60 Mn |
| Sep 30, 2025 | 573.75 Mn |
| Jun 30, 2025 | 402.74 Mn |
| Mar 31, 2025 | 417.36 Mn |
| Dec 31, 2024 | 467.77 Mn |
| Sep 30, 2024 | 466.13 Mn |
| Jun 30, 2024 | 300.61 Mn |
| Mar 31, 2024 | 331.00 Mn |
| Dec 31, 2023 | 170.44 Mn |
| Sep 30, 2023 | 176.68 Mn |
| Jun 30, 2023 | 196.54 Mn |
| Mar 31, 2023 | 202.36 Mn |
| Dec 31, 2022 | 183.72 Mn |
| Sep 30, 2022 | 144.45 Mn |
| Jun 30, 2022 | 120.65 Mn |
| Mar 31, 2022 | 131.68 Mn |
| Dec 31, 2021 | 154.63 Mn |
| Sep 30, 2021 | 98.72 Mn |
API Access
Kymera Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();